US pauses J&J COVID-19 vaccine over rare blood clots

U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women under 50 who had received it developed rare blood clots, dealing a fresh setback to efforts to tackle the pandemic.